Cogentix Medical, Inc.
CGNT
CGNT was delisted on the 20th of April, 2018.
47 hedge funds and large institutions have $39.1M invested in Cogentix Medical, Inc. in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
40% more capital invested
Capital invested by funds: $27.9M → $39.1M (+$11.2M)
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
7% more funds holding
Funds holding: 44 → 47 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$3.31M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
| 3 |
Millennium Management
New York
|
+$1.07M |
| 4 |
Renaissance Technologies
New York
|
+$928K |
| 5 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$805K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$2.11M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.37M |
| 3 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$697K |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
-$484K |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$374K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GC
51
GMT Capital
Atlanta,
Georgia
| – | -$67K | -21,304 | Closed |
|
52
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$63K | -20,040 | Closed |
|
|
AGM
53
Alpine Global Management
New York
| – | -$57K | -18,150 | Closed |
|
54
Stifel Financial
St. Louis,
Missouri
| – | -$34K | -10,786 | Closed |
|
55
JP Morgan Chase
New York
| – | -$17K | -5,300 | Closed |
|
|
AG
56
Advisor Group
Phoenix,
Arizona
| – | -$5K | -1,500 | Closed |
|
57
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -438 | Closed |
|
58
Citigroup
New York
| – | +$125 | +40 | New |
|
CGNT Hedge Fund Activity: Q1 2018 in Review
47 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q1 2018, worth a combined $39.1M — up 40% from $27.9M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CGNT positions and 11 closed out — a net gain of 3 holders — while 13 added to existing stakes and 7 trimmed.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $3.31M. The largest seller was Broadfin Capital, exiting entirely with an estimated $2.11M sold.
- 47 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q1 2018, up from 44 in Q4 2017.
- Funds reported $39.1M of Cogentix Medical, Inc. stock for Q1 2018, up 40% quarter-over-quarter.
- 14 funds opened new Cogentix Medical, Inc. positions in Q1 2018 and 11 closed out, a net change of +3 holders.
- The largest Cogentix Medical, Inc. buyer in Q1 2018 was Beryl Capital Management, an estimated $3.31M added.
- The largest Cogentix Medical, Inc. seller in Q1 2018 was Broadfin Capital, an estimated $2.11M sold.
Based on aggregated 13F filings for Q1 2018.